Kentaro Sawada

1.3k total citations
59 papers, 633 citations indexed

About

Kentaro Sawada is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Kentaro Sawada has authored 59 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 33 papers in Oncology and 23 papers in Surgery. Recurrent topics in Kentaro Sawada's work include Gastric Cancer Management and Outcomes (28 papers), Colorectal Cancer Treatments and Studies (25 papers) and Cancer Genomics and Diagnostics (9 papers). Kentaro Sawada is often cited by papers focused on Gastric Cancer Management and Outcomes (28 papers), Colorectal Cancer Treatments and Studies (25 papers) and Cancer Genomics and Diagnostics (9 papers). Kentaro Sawada collaborates with scholars based in Japan, United States and South Korea. Kentaro Sawada's co-authors include Takayuki Yoshino, Yoshiaki Nakamura, Yoshito Komatsu, Satoshi Yuki, Daisuke Kotani, Naoya Sakamoto, Hiroya Taniguchi, Satoshi Fujii, Saori Mishima and Yasutoshi Kuboki and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Kentaro Sawada

51 papers receiving 630 citations

Peers

Kentaro Sawada
Kentaro Sawada
Citations per year, relative to Kentaro Sawada Kentaro Sawada (= 1×) peers Ryo Sugimoto

Countries citing papers authored by Kentaro Sawada

Since Specialization
Citations

This map shows the geographic impact of Kentaro Sawada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kentaro Sawada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kentaro Sawada more than expected).

Fields of papers citing papers by Kentaro Sawada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kentaro Sawada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kentaro Sawada. The network helps show where Kentaro Sawada may publish in the future.

Co-authorship network of co-authors of Kentaro Sawada

This figure shows the co-authorship network connecting the top 25 collaborators of Kentaro Sawada. A scholar is included among the top collaborators of Kentaro Sawada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kentaro Sawada. Kentaro Sawada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sakai, Daisuke, Shigenori Kadowaki, Ryohei Kawabata, et al.. (2025). Randomized Phase III Trial of Ramucirumab Beyond Progression Plus Irinotecan in Patients With Ramucirumab-Refractory Advanced Gastric Cancer: RINDBeRG Trial. Journal of Clinical Oncology. 43(19). 2196–2207. 3 indexed citations
2.
Tsuboi, Takashi, Takashi Uematsu, Kentaro Sawada, et al.. (2025). Determinants of clinical and neurophysiological features in essential tremor and essential tremor plus. Journal of Neural Transmission. 132(7). 1041–1050. 1 indexed citations
3.
Bando, Hideaki, Toshihiro Yamaguchi, Seiichiro Mitani, et al.. (2024). Japanese Society of Medical Oncology clinical guidelines: Molecular testing for colorectal cancer treatment, 5th edition. Cancer Science. 115(3). 1014–1021. 3 indexed citations
5.
Sakai, Shunsuke, Takao Fujisawa, Kentaro Sawada, et al.. (2023). Interim analysis results of gut microbiota in patients with unresectable cholangiopancreatic cancer: SCRUM-Japan MONSTAR-SCREEN.. Journal of Clinical Oncology. 41(4_suppl). 733–733.
6.
Kawakami, Takeshi, Toshiki Masuishi, Yasuyuki Kawamoto, et al.. (2022). The survival benefit of increasing the number of active drugs for metastatic colorectal cancer: A multicenter retrospective study. Cancer Medicine. 11(11). 2184–2192. 1 indexed citations
7.
Nakamura, Michio, Atsushi Ishiguro, Yasuyuki Kawamoto, et al.. (2022). Feasibility of edoxaban for asymptomatic cancer-associated thrombosis in Japanese patients with gastrointestinal cancer: ExCAVE study. BMC Cancer. 22(1). 1322–1322.
8.
Shibata, Chikashi, Toru Nakano, Kentaro Sawada, et al.. (2022). Comparison of CEA and CA19-9 as a predictive factor for recurrence after curative gastrectomy in gastric cancer. BMC Surgery. 22(1). 213–213. 48 indexed citations
9.
Sawada, Kentaro, Daisuke Kotani, Hiroki Yukami, et al.. (2022). Definitive chemoradiotherapy has comparable survival outcomes to esophagectomy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: real-world data. International Journal of Clinical Oncology. 27(8). 1279–1288. 2 indexed citations
10.
Taniguchi, Hiroya, Yoshiaki Nakamura, Daisuke Kotani, et al.. (2021). CIRCULATE‐Japan: Circulating tumor DNA–guided adaptive platform trials to refine adjuvant therapy for colorectal cancer. Cancer Science. 112(7). 2915–2920. 92 indexed citations
11.
Sasaki, Akinori, Akihito Kawazoe, Saori Mishima, et al.. (2020). Improved efficacy of taxanes and ramucirumab combination chemotherapy after exposure to anti-PD-1 therapy in advanced gastric cancer. ESMO Open. 5(4). e000775–e000775. 30 indexed citations
12.
Kubota, Yohei, Akihito Kawazoe, Akinori Sasaki, et al.. (2020). The Impact of Molecular Subtype on Efficacy of Chemotherapy and Checkpoint Inhibition in Advanced Gastric Cancer. Clinical Cancer Research. 26(14). 3784–3790. 54 indexed citations
14.
Shibata, Chikashi, Hitoshi Ogawa, Toru Nakano, et al.. (2019). Influence of age on postoperative complications especially pneumonia after gastrectomy for gastric cancer. BMC Surgery. 19(1). 106–106. 22 indexed citations
15.
Nakamura, Yoshiaki, Kentaro Sawada, Satoshi Fujii, & Takayuki Yoshino. (2019). HER2-targeted therapy should be shifted towards an earlier line for patients with anti-EGFR-therapy naïve, HER2-amplified metastatic colorectal cancer. ESMO Open. 4(3). e000530–e000530. 5 indexed citations
17.
Komatsu, Yoshito, Kentaro Sawada, Toshiya Muranaka, et al.. (2016). P-168 Retrospective comparison of efficacy and safety of docetaxel and weekly-paclitaxel as 2nd-line chemotherapy for patients with unresectable or recurrent esophageal cancer. Annals of Oncology. 27. ii50–ii50. 2 indexed citations
18.
Chihara, Shingo, Kentaro Sawada, Hiroshi Tomoeda, & Shigeaki Aoyagi. (2016). Pulsatile Varicose Veins Secondary to Severe Tricuspid Regurgitation: Report of a Case Successfully Managed by Endovenous Laser Treatment. Annals of Vascular Surgery. 39. 286.e11–286.e14. 6 indexed citations
19.
Hiromatsu, Shinichi, Kentaro Sawada, Eiji Nakamura, et al.. (2014). Hybrid Treatment of the Intrathoracic Right Subclavian Artery Aneurysm. Japanese Journal of Cardiovascular Surgery. 43(5). 270–273. 1 indexed citations
20.
Sawada, Kentaro, et al.. (1997). Distribution and Neuropeptide Content of Nitric Oxide Synthase-Containing Nerve Fibers in Arteries and Conduction System of the Rat Heart. Cells Tissues Organs. 160(4). 239–247. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026